From the Black press
Community · Miami, FL
Ivonescimab Receives NMPA Priority Review for First-Line Biliary Tract Cancer
HONG KONG, Nov. 4, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) today announced that ivonescimab in combination with chemotherapy for the first-line treatment of locally advanced or metastatic
M
Continue reading
The full story is at The Miami Times.
The Miami Times reported this story. TUEPAC carries the headline and opening so you can find it here; the reporting, photos, and readership stay with the publisher.
Continue at miamitimesonline.com ↗Opens the publisher's site
Stay on this
Follow what you care about and we send a weekly digest, every story linked to its publisher.
More from The Miami TimesAll headlines →
Kyndryl Uses Agentic AI to Accelerate Enterprise Modernization with AWS
4HNSING Technologies Surpasses 250 Million Bluetooth Chips Shipped Powered by Ceva Technology
4HTrue Star Garage Doors Outlines When Homeowners Should Repair or Replace Garage Doors
4HHeadline and an excerpt of at most 40 words from the publisher's public feed. This page's canonical URL points to the original at miamitimesonline.com. How we carry publishers' work · Publisher: see your report